Wenmiao Shu

Prof. Wenmiao Shu

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2018 in Bioactive Materials
Verified
Journal Article
Open access
GTGareth Turnbull
Gareth Turnbull
JCJon Clarke
Jon Clarke
FPFrédéric Picard
Frédéric Picard
PRPhilip Riches
Philip Riches
LJLuanluan Jia
Luanluan Jia
WSWenmiao Shu
Wenmiao Shu
Bone is the second most commonly transplanted tissue worldwide, with over four million operations using bone grafts or bone substitute materials annually to treat bone defects. However, significant limitations affect current treatment options and clinical demand for bone grafts continues to rise due to conditions such as trauma, cancer, infection and arthritis. Developing bioactive three-dimensional (3D) scaffolds to support bone regeneration has therefore become a key area of focus within bone tissue engineering (BTE). A variety of materials and manufacturing methods including 3D printing have been used to create novel alternatives to traditional bone grafts. However, individual groups of materials including polymers, ceramics and hydrogels have been unable to fully replicate the properties of bone when used alone. Favourable material properties can be combined and bioactivity improved when groups of materials are used together in composite 3D scaffolds. This review will therefore consider the ideal properties of bioactive composite 3D scaffolds and examine recent use of polymers, hydrogels, metals, ceramics and bio-glasses in BTE. Scaffold fabrication methodology, mechanical performance, biocompatibility, bioactivity, and potential clinical translations will be discussed.

8 January 2016 in Biofabrication
Verified
Journal Article
Closed access
PDF file
JGJürgen Groll
Jürgen Groll
Thomas BolandThomas Boland
Thomas Boland
TBTorsten Blunk
Torsten Blunk
JBJason A Burdick
Jason A Burdick
DCDong-Woo Cho
Dong-Woo Cho
JMJos Malda
Jos Malda
Biofabrication is an evolving research field that has recently received significant attention. In particular, the adoption of Biofabrication concepts within the field of Tissue Engineering and Regenerative Medicine has grown tremendously, and has been accompanied by a growing inconsistency in terminology. This article aims at clarifying the position of Biofabrication as a research field with a special focus on its relation to and application for Tissue Engineering and Regenerative Medicine. Within this context, we propose a refined working definition of Biofabrication, including Bioprinting and Bioassembly as complementary strategies within Biofabrication.

1 April 2018 in Trends in Biotechnology
Verified
Journal Article
Closed access
Lorenzo MoroniLorenzo Moroni
Lorenzo Moroni
Thomas BolandThomas Boland
Thomas Boland
JBJason A. Burdick
Jason A. Burdick
Carmelo De MariaCarmelo De Maria
Carmelo De Maria
BDBrian Derby
Brian Derby
Giovanni VozziGiovanni Vozzi
Giovanni Vozzi

21 October 2015 in Biofabrication
Verified
Journal Article
Open access
PDF file
AFAlan Faulkner-Jones
Alan Faulkner-Jones
CFCatherine Fyfe
Catherine Fyfe
DCDirk-Jan Cornelissen
Dirk-Jan Cornelissen
JGJohn Gardner
John Gardner
JKJason King
Jason King
WSWenmiao Shu
Wenmiao Shu
We report the first investigation into the bioprinting of human induced pluripotent stem cells (hiPSCs), their response to a valve-based printing process as well as their post-printing differentiation into hepatocyte-like cells (HLCs). HLCs differentiated from both hiPSCs and human embryonic stem cells (hESCs) sources were bioprinted and examined for the presence of hepatic markers to further validate the compatibility of the valve-based bioprinting process with fragile cell transfer. Examined cells were positive for nuclear factor 4 alpha and were demonstrated to secrete albumin and have morphology that was also found to be similar to that of hepatocytes. Both hESC and hiPSC lines were tested for post-printing viability and pluripotency and were found to have negligible difference in terms of viability and pluripotency between the printed and non-printed cells. hESC-derived HLCs were 3D printed using alginate hydrogel matrix and tested for viability and albumin secretion during the remaining differentiation and were found to be hepatic in nature. 3D printed with 40-layer of HLC-containing alginate structures reached peak albumin secretion at day 21 of the differentiation protocol. This work demonstrates that the valve-based printing process is gentle enough to print human pluripotent stem cells (hPSCs) (both hESCs and hiPSCs) while either maintaining their pluripotency or directing their differentiation into specific lineages. The ability to bioprint hPSCs will pave the way for producing organs or tissues on demand from patient specific cells which could be used for animal-free drug development and personalized medicine.

7 February 2020 in Biofabrication
Verified
Journal Article
Open access
PDF file
WSWei Sun
Wei Sun
BSBinil Starly
Binil Starly
ADAndrew C Daly
Andrew C Daly
Jason BurdickJason Burdick
Jason Burdick
JGJürgen Groll
Jürgen Groll
Ibrahim Tarik OzbolatIbrahim Tarik Ozbolat
Ibrahim Tarik Ozbolat
This bioprinting roadmap features salient advances in selected applications of the technique and highlights the status of current developments and challenges, as well as envisioned advances in science and technology, to address the challenges to the young and evolving technique. The topics covered in this roadmap encompass the broad spectrum of bioprinting; from cell expansion and novel bioink development to cell/stem cell printing, from organoid-based tissue organization to bioprinting of human-scale tissue structures, and from building cell/tissue/organ-on-a-chip to biomanufacturing of multicellular engineered living systems. The emerging application of printing-in-space and an overview of bioprinting technologies are also included in this roadmap. Due to the rapid pace of methodological advancements in bioprinting techniques and wide-ranging applications, the direction in which the field should advance is not immediately clear. This bioprinting roadmap addresses this unmet need by providing a comprehensive summary and recommendations useful to experienced researchers and newcomers to the field.

5 February 2015 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
CLChuang Li
Chuang Li
AFAlan Faulkner-Jones
Alan Faulkner-Jones
ADAlison R. Dun
Alison R. Dun
JJJuan Jin
Juan Jin
PCPing Chen
Ping Chen
RDRory R. Duncan
Rory R. Duncan